This article explores the complex interplay between drug addiction and HIV, highlighting how integrated harm reduction ...

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be ...

The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts ...

Colombian billionaire Jaime Gilinski Bacal is open to selling his majority stake in British lender Metro Bank and has ...

The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that ...

FDA Approves Yeztugo as First Twice-Yearly Injectable HIV Prevention Option in the U.S. Clinical Trials Show Near-Perfect ...

Key Takeaways A cheap HIV drug appears to reverse vision loss caused by diabetic macular edemaLamivudine caused a dramatic ...

June 19, 2025 – The FDA has approved the first twice-yearly shot to reduce the risk of HIV infections.

FDA approves Yeztugo HIV prevention injection showing 96% efficacy in clinical trials, but $14,000 cost creates significant ...

The approach employed by the research team could be used against other diseases—including COVID-19 and influenza.

Individuals at risk for sexually acquired HIV have a new injectable option for preexposure prophylaxis (PrEP) with the US ...